INFLUENCE OF CARDONAT ON INDICATORS OF BIOCHEMICAL AND HORMONAL HOMEOSTASIS IN SPORTSMANS WITH CARDIOMYOPATHY AFTER PHYSICAL OVERLOAD

V. V. Bezugla; L. M. Gunina; Yu. D. Vinnichuk; V. V. Klapchuk

V. V. Bezugla "Ukrainian Medical Center of Sports Medicine of the Ministry of Health of Ukraine", 6 Tarasivska str., Kyiv, Ukraine
L. M. Gunina National Anti-Doping Center of Ukraine, 8 Aircraft designer Igor Sikorsky str, Kiev, Ukraine
Yu. D. Vinnichuk Research Institute of the National University of Physical Education and Sports of Ukraine, 1 Fizkultury str., Kiev, Ukraine
V. V. Klapchuk Zaporizhzhia National Technical University, 39 Turgenieva str., Zaporizhzhia, Ukraine

Keywords: athletes, Cardonat, biochemical and hormonal homeostasis, prooxidant-antioxidant balance, cardiomyopathy, chronic overstrain

Abstract

Introduction. Modern sport of the highest achievements is inextricably linked with the constant physical activity of high intensity, which ultimately leads to the formation of overvoltage phenomena of various body systems.

The purpose. To substantiate the expediency of appointment of athletes with clinical and instrumental signs of the cardiomyopathy, caused by chronic physical overload (CMPCPO) of the metabolic preparation Cardonat on the basis of evaluation of its influence on the indices of biochemical and hormonal homeostasis.

Materials and methods. The study involved 48 athletes, representatives of cyclic sports, with a diagnosis CMPCPO who were randomized to 2 equivalent (n = 24) groups: the main group and the controls. The volume and intensity of training loads was reduced in athletes of both groups by 75%. The control group participants received only basic therapy (the combination of the drug panangin (potassium and magnesium aspartate) and the drug Trіovіt, at therapeutic doses of vitamin-mineral orientation and placebo (capsule with starch). Athletes of the main group in addition to basic therapy used Cardonat for one capsule three times a day for 4 weeks. A comprehensive laboratory study of athletes before and after the course of treatment included a study of the indicators of biochemical and hormonal homeostasis, as well as prooxidant-antioxidant balance.

Results. The addition of Cardonat to the complex therapy of athletes from the CMPCPO during the month is accompanied by a positive effect on the structural characteristics of the erythrocyte membranes of the athletes, which is reflected in the improvement of the state of prooxidant-antioxidant equilibrium: in the representatives of the main group, the administration of the drug caused a statistically significant decrease, compared with the data in the control group, malodialdehyde (MDA), increase in the concentration of reduced glutathione (GSH) in erythrocyte membranes and decrease of prooxidant-antioxidant coefficient (C_pa), indicating the predominance of antioxidant processes over lipopereoxidation processes. It is also shown that taking a Cardonat with athletes with manifestations CMPCPO is not accompanied by negative changes in standard laboratory biochemical parameters that reflect the functional state of various organs and systems of the body's organs. The decrease in the activity of aspartate aminotransferase (AST) and the tendency towards a more pronounced decrease in alanine aminotransferase (ALT), α-amylase and urea content in comparison with the values of the corresponding indices in the control group, confirms the positive effect of the drug on the functional state of the liver and pancreas. Indicators of hormonal homeostasis are indicative of improving the ratio of anabolic and catabolic processes in the body of athletes and reducing the level of stress due to the use of the drug. Thus, after taking Cardonat in the main group, testosterone levels increased by 31.6 % (р < 0.05) compared to baseline data, and cortisol decreased by 63.8 % (р < 0.05); the average index of anabolism in the main group after treatment increased by 58.9 % (р < 0.05), which indicates a significant increase in the rate of anabolic processes.

Conclusions. The additional use of сardonat in therapy is safe, expedient, pathogenetically justified, in particular for the treatment of homeostatic shifts in the body of athletes with clinical and electrocardiographic manifestations of CMPСPО.

Downloads

Download data is not yet available.

References

1. Platonov V. [Overtraining in sport]. Science in Olympic Sport. 2015;1:19–34.
2. Carfagno DG, Hendrix JC 3rd. Overtraining syndrome in the athlete: current clinical practice. Curr Sports Med Rep. 2014;13(1):45–51.
3. Nikulin BA, Rodionova II. Biohimicheskiy kontrol v sporte [Biochemical control in sports]. Moskwa: Sovetsky sport publ., 2011. 228 p.
4. Makarova GA, Loktev SA. [Меthodological principles of analysis and assessment of physiological, clinical and laboratory parameters in athletes]. LFK i massazh. 2016;2:4–12.
5. Afanaseva IA. Pokazateli gomeostaza sportsmenov pri fizicheskih nagruzkah raznoy intensivnosti [Homeostasis indices of athletes under physical loads of similar intensities]. SPb: Izd-vo «Olimp–SPb.», 2011. 100 р.
6. Taymazov VA, Afanaseva NA. [Overtraining syndrome in athletes: endogenic intoxication and factors of innate immunity]. Uchenyie zapiski un-ta im. P. F. Lesgafta. 2011;12(82): 24–30.
7. Filippov MM, Davidenko DN. Fiziologicheskie mekhanizmy razvitiya i kompensacii sostoyaniya gipoksii v processe adaptacii k myshechnoj deyatel'nosti [Physiological mechanisms of development and compensation of hypoxia in the process of adaptation to muscular activity]. St. Petersburg. Kiev: BPA, 2010. 260 p.
8. Gunina LM, Vinnychuk YuD. [Tissue hypoxia and associated changes in homeostasis under vibratory loads in athletes: the impact on physical performance]. Physiol journal. 2014;60(4):61–69.
9. Girard O, Brocherie F, Millet GP. Effects of Altitude/Hypoxia on Single- and Multiple-Sprint Performance: A Comprehensive Review. Sports Med. 2017;47(10):1931–1949.
10. Rozhkova EA, Seyfulla RD, Volkov SK. [Oxidative stress is a universal pathogenetic mechanism of development of physical overexertion in athlete’s body: a review of scientific literature]. Sports medicine. 2010;1-2:29–36.
11. Vasilenko VS, Lopatin ZV. [Оxidative stress and endothelial dysfunction in athletes as a risk factor for cardiomyopathy overstrain]. Sovremennyie problemyi nauki i obrazovaniya. 2019;1. Retrieved from: http://www.science-education.ru/ru/article/view?id=28488
12. Gryaznyih AV. [Testosterone/cortisol index as an endocrine marker of visceral system recovery after muscle activity]. Vestnik YuUrGU. 2015;20(237):207–211.
13. Maunder E, Kilding AE, Plews DJ. Substrate Metabolism During Ironman Triathlon: Different Horses on the Same Courses. Sports Med. 2018;48(10):2219–2226.
14. Gavrilova EA. Sportivnoe serdtse. Stressornaya kardiomiopatiya [Athletic heart. Stressor cardiomyopathy]. Moskwa: Sovetsky sport publ., 2007. 198 p.
15. Poortmans JR, Carpentier A, Pereira-Lancha LO, Lancha A Jr. Protein turnover, amino acid requirements and recommendations for athletes and active populations. Braz J Med Biol Res. 2012;45(10):875–890.
16. Klapchuk VV, Bezugla VV,. Vinnichuk YuD. [Assessment of cardonat efficiency in cardiomyopathy treatment after physical overload in athletes]. J Clin Exp Med Res, 2018;6(4):396–408.
17. Sokolova NI, Vladimirova NМ, Теmkina ОЕ, Vasilenko YN. [Metabolic therapy impact on athletes’ functional state]. Novosti meditsiny i farmatsiyi. 2005;9(169):6–7.
18. Kryilov VN, Deryugina AV. [Typical changes in the electrophoretic mobility of erythrocytes under stress effects]. Byull. eksper. biol. i meditsinyi. 2005;4:364–366.
19. Bankova VV, Prischepova NF, Avratinskiy OI. [The method of assessing the pathological changes of the plasma membrane in children with various diseases] Patol. fiziol. i eksper. terapiya. 1987;3:78–81.
20. Shvets NI, Davyidov VV. [Age characteristics of changes in the glutathione system in the heart of rats during immobilization stress]. Ukr biokhimichnyi zhurnal. 2008;6(80):74–78.
21. Hunina LM, Oliinyk SA, Ivanov SV. [Changes in blood parameters and prooxidant-antioxidant balance in erythrocyte membranes with intense physical activity]. Medychna khimiia. 2007;9(1):91–99.
22. Lang TA, Sesik M. Kak opisyvat' statistiku v medicine: rukovodstvo dlya avtorov, redaktorov i recenzentov [How to describe statistics in medicine: a guide for authors, editors and reviewers]. Moskva: Prakticheskaya medicina, 2011. 480 p.
23. Gunina LM, Vinnichuk YuD., Nosach YeV. Biohimicheskie markeryi utomleniya pri fizicheskoy nagruzke: metod .rek. [Biochemical markers of fatigue under physical exertion: methodol. recommend.]. Kyiv: NUPESU; 2013. 35 p.
24. Gavrilova YeA. Stressornyiy immunodefitsit u sportsmenov [Stress immunodeficiency in athletes]. M.: Sovetskiy sport; 2009. 192 p.
25. Hughes JD, Denton K, S Lloyd R, Oliver JL, De Ste Croix M. The Impact of Soccer Match Play on the Muscle Damage Response in Youth Female Athletes. Int J Sports Med. 2018;39(5): 343–348.
26. Jin CH, Paik IY, Kwak YS, Jee YS, Kim JY. Exhaustive submaximal endurance and resistance exercises induce temporary immunosuppression via physical and oxidative stress. Exerc Rehabil. 2015;11(4):198-203.
27. Chekman IS, Gorchakova NA, Francuzova SB, Nagornaya EA. Metabolitnye i metabolitotropnye preparaty v sisteme kardio- i organoprotekcii [Metabolitic and metabotropotropic drugs in the system of cardio and organoprotection]. Kyiv: Polihraf plius, 2009. 155 p.
28. Zagayko AL, Briukhanova TO, Shynkariov AA, Melnyk NV. [Metabolic effects of carnitine, role in development of pathologies and prospects of clinical application (review)]. Ukrainian biopharmaceutical journal. 2016;6(47):17–22.
29. de Oliveira DCX, Rosa FT, Simões-Ambrósio L, Jordao AA, Deminice R. Antioxidant vitamin supplementation prevents oxidative stress but does not enhance performance in young football athletes. Nutrition. 2019;63-64:29–35.